MM+M announces 2024's 40 Under 40 honorees
In its fifth year, the 40 Under 40 program celebrates the industry’s most highly regarded young talent.
Stay updated with breaking news from Johnson Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In its fifth year, the 40 Under 40 program celebrates the industry’s most highly regarded young talent.
First trial in AMI cardiogenic shock to use the FDA’s EFIC protocol
Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).
DANVERS — Abiomed, part of Johnson & Johnson MedTech, hosted its annual Thanksgiving luncheon for employees on Tuesday, Nov. 14. Members of Abiomed’s executive team served more than 1,000 employees
Partnership will prioritise addressing health inequalities in the region